Members Login
Channels
Special Offers & Promotions
« Monday, 16 November 2015 »
- Biosimilars & Biobetters USA - (16/11/2015 09:00 - 17/11/2015 17:00)
Biologic Therapeutics have revolutionised the treatment of many diseases and biosimilars are having a similar therapeutic efficacy with potentially lower costs to the health care system. The approval of the first biosimilar in the US is expected to save the healthcare industry and patients $5.7 billion over the next decade. However, it is a complex landscape with complexity of manufacturing biologics making the development of biosimilars more challenging than the development of generics.
Media Partners